On Wednesday (12 May), the CDC announced that the Pfizer vaccine could now be given to 12-15 year olds - effective immediately for 17 million adolescents.
Lorraine Smith, Divisional Managing Director at Civica, discusses how the pandemic has not only re-shaped local government when it comes to new ways of working but also in transforming citizen engagement.
Adam Enterkin, Global SVP Sales at BlackBerry, explores the critical role of secure crisis communications for the vaccine rollout and the value of a communication strategy to combat misinformation.
Supplies of critical minerals essential for key clean energy technologies like electric vehicles and wind turbines, will need to increase significantly over the coming decades to meet the world’s climate goals.
John Bell, director and founder of Clarke Bell, ponders the impact of COVID-19 on the economy and what options struggling businesses could be facing in the coming months and years ahead.
A new study aims to explore the immune response to COVID-19 infection and vaccination in patients with antibody deficiencies.
Ram May-Ron, Managing Partner at FreeMind Group, explains why COVID vaccine development was exceptionally speedy.
Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.
Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.
Peter Seldon, CEO, Consultus Care and Nursing, explores the impact of COVID-19 and mental health within social care settings and what best practices can be adopted to support both carers and clients.
Here, Deirdre Figueiredo, MBE and Director of Craftspace, discusses the relationship between art, community and mental health during lockdown.
Nepal, which shares a long border with hard-hit India, is experiencing a meteoric rise in COVID-19 cases and facing an oxygen shortage.
According to a new study by researchers at UCL, mild COVID-19 infection is highly unlikely to cause lasting heart damage.
COVID-19 testing must go hand-in-hand with the vaccines in order for the UK to come out of the crisis successfully.